Is FSTX or O a better dividend investment in 2026?

FSTX currently yields 28.09% with a 5% 5-year dividend growth rate. O yields 5.28% with 3.2% growth. The better choice depends on your goal: FSTX offers higher current income.

What is the dividend yield difference between FSTX and O?

FSTX has a forward dividend yield of 28.09% ($2.00/share annually). O yields 5.28% ($3.23/share annually). The yield gap is 22.81 percentage points.

Home › Compare › FSTX vs O

FSTX vs O: Dividend Comparison 2026

FSTX yields 28.09% · O yields 5.28%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 FSTX wins by $84.2K in total portfolio value

INVESTMENT

TIME HORIZON10 years

FSTX

● Live price

28.09%

Share price

$7.12

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$118.5K

Annual income

$14,804.06

Full FSTX calculator →

Realty Income Corporation

● Live price

5.28%

Share price

$61.15

Annual div

$3.23

5Y div CAGR

15.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.2K

Annual income

$5,102.74

Full O calculator →

Portfolio growth — FSTX vs O

📍 FSTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	FSTX	O
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, FSTX + O cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

FSTX pays

O pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSTX

Annual income on $10K today (after 15% tax)

$2,387.64/yr

After 10yr DRIP, annual income (after tax)

$12,583.45/yr

Annual income on $10K today (after 15% tax)

$449.12/yr

After 10yr DRIP, annual income (after tax)

$4,337.33/yr

At 15% tax rate, FSTX beats the other by $8,246.12/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSTX + O for your $10,000?

FSTX: 50%O: 50%

100% O50/50100% FSTX

Portfolio after 10yr

$76.4K

Annual income

$9,953.40/yr

Blended yield

13.04%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

FSTX

No analyst data

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$64.00

+4.7% upside vs current

Range: $60.00 — $69.00

Altman Z

1.0

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSTX buys

O buys

No recent congressional trades found for FSTX or O in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricFSTXO

Forward yield	28.09% ✓	5.28%
Annual dividend / share	$2.00	$3.23 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.1% ✓
Portfolio after 10y	$118.5K ✓	$34.2K
Annual income after 10y	$14,804.06 ✓	$5,102.74
Total dividends collected	$78.8K ✓	$20.7K
Payment frequency	quarterly	monthly
Sector	Stock	REIT

Year-by-year: FSTX vs O ($10,000, DRIP)

Year	FSTX Portfolio	FSTX Income/yr	O Portfolio	O Income/yr	Gap
1← crossover	$13,509	$2,808.99	$10,818	$608.16	+$2.7K → FSTX
2	$18,001	$3,546.41	$11,787	$741.68	+$6.2K → FSTX
3	$23,678	$4,416.52	$12,946	$911.00	+$10.7K → FSTX
4	$30,764	$5,429.21	$14,345	$1,127.94	+$16.4K → FSTX
5	$39,510	$6,592.67	$16,056	$1,409.05	+$23.5K → FSTX
6	$50,189	$7,913.03	$18,171	$1,777.83	+$32.0K → FSTX
7	$63,097	$9,394.15	$20,820	$2,268.21	+$42.3K → FSTX
8	$78,551	$11,037.47	$24,188	$2,929.90	+$54.4K → FSTX
9	$96,891	$12,841.93	$28,533	$3,837.11	+$68.4K → FSTX
10	$118,478	$14,804.06	$34,235	$5,102.74	+$84.2K → FSTX

FSTX vs O: Complete Analysis 2026

FSTX — Stock

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.

Full FSTX Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →

📬

Get this FSTX vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSTX vs SCHD FSTX vs JEPI FSTX vs KO FSTX vs MAIN FSTX vs STAG FSTX vs ADC FSTX vs NNN FSTX vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.